ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1919

Rheumatology-Ophthalmology Collaborative Uveitis Units May Improve The Diagnostic Approach Of This Pathology: Experience From a Uveitis Unit In a Secondary Spanish Hospital

Elena Aurrecoechea1, Ana Diez del Corral2, Angel de la Mora2, Jaime Calvo-Alén3 and Ernesto Romera4, 1Hospital Sierrallana. Torrelavega, Torrelavega, Spain, 2Ophthalmology, Ophthalmology Unit Hospital Sierrallana, Torrelavega, Spain, 3Rheumatology, Hospital Universitario Sierrallana, Torrelavega, Spain, 4Ophthalmology, Hospital Sierrallana Torrelavega, Torrelavega, Spain

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Uveitis

  • Tweet
  • Email
  • Print
Session Information

Title: Health Services Research, Quality Measures and Quality of Care - Innovations in Health Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose: Uveitis is defined as an intraocular inflammation, and may be associated to a systemic disease, it has a worldwide distribution, and it is a significant cause of blindness. As such the creation of Uveitis Units with the association of Rheumatologists and Ophthalmologists is highly recommended. The aim of this study is analyze the Etiology of the Uveitis diagnosed in the first three years of this unit and share our experience.

Methods: This study includes 125 patients, new and long standing, with Uveitis examined in the last three years. All patients were evaluated by the Ophthalmologist and the Rheumatologist including a detailed history and examination. A questionnaire about family and medical history were given (a Spanish translation from uveitis.org questionnaire), and guided by the evaluation  a blood test, chest ray, OCT , retinal angiography or other test were ordered as needed.

Results: The most common form of uveitis was anterior uveitis (67.2%) and the most common diagnoses were Idiopathic (44%), Ankylosing spondylitis (17.8%), Herpes (14.3%), HLA-B27 (9.5%), Fuchs Heterochromic Iridocyclitis( 3.5%).

The second most common uveitis type was posterior uveitis (16.8%) and the most common diagnoses were toxoplasmosis (42.9%), Serpiginous  choroidopathy (23.8%), idiopathic  (23.8%),  Tuberculosis (4.8%) and Vogt Koyanagi Harada disease (4.8%).

Panuveitis was diagnosed in 8.8% of the cases and the most frequent causes were idiopathic (54%), Behçet’s disease (18.8%), Endophthalmitis (9%), and Toxoplasmosis (9%).

The less frequent type of uveitis was intermediate uveitis with 7.2% of the diagnoses, most of the cases were idiopathic (66.6%), but sarcoidosis (11%), syphilis (11%), and multiple sclerosis (11%) were other etiologies found.

 There were no eyes with final visual acuity worse than 20/200 in these 3 years with non-infectious uveitis.

Anterior  Uveitis                       67.2%

Intermediate

 Uveitis                 7.2%

Posterior

Uveitis              16.8%

Panuveitis               8.8%

Idiopathic                                 44%

Idiopathic           66.6%

Toxoplasmosis  42.9%

Idiopathic               54.4%

Ankylosing Spondylitis            17.8%

Multiple                

Sclerosis             11%    

Serpiginous 

choroidopathy   23.8%

Behçet’s

 disease                   18.8%

Herpes                                     14.3%

Syphilis               11%

Idiopathic          23.8%

Endophthalmitis        9%

HLA-B27+                                 9.5%

Sarcoidosis         11%

Tuberculosis        4.8%

Toxoplasmosis          9%

Fuchs heterochromic

 Iridocyclitis                             3.5%

VKH                      4.8%

 

Psoriasis                                   2.4%

 

 

 

Sarcoidosis                               2.4%

 

 

 

AIJ                                            2.4%

 

 

 

TINU                                         1.2%

 

 

 

IBD                                           1.2%

 

 

 

Rheumatoid arthritis                1.2%

 

Conclusion: This secondary center based study shows the  type and etiology of uveitis in our population, and how a multidisciplinary approach can improve the rate of diagnosis and prognosis for patients permitting a ready access to new and better treatments in an effective way, leading to a satisfying experience for the Rheumatologist and Ophthalmologist alike.



Disclosure:

E. Aurrecoechea,
None;

A. Diez del Corral,
None;

A. de la Mora,
None;

J. Calvo-Alén,
None;

E. Romera,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatology-ophthalmology-collaborative-uveitis-units-may-improve-the-diagnostic-approach-of-this-pathology-experience-from-a-uveitis-unit-in-a-secondary-spanish-hospital/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology